|
市場調査レポート
商品コード
1388351
手術用顕微鏡の世界市場:規模、シェア、動向分析(2024年~2030年):MedCore - 眼科/検眼用顕微鏡、脳神経外科/脊椎用顕微鏡、耳鼻咽喉科用顕微鏡、形成外科用顕微鏡Surgical Microscope Market Size, Share, and Trends Analysis | Global | 2024-2030 | MedCore | Includes: Ophthalmology/Optometry Microscopes, Neurosurgery/Spine Microscopes, ENT Microscopes, and Plastic Reconstructive Microscopes |
||||||
適宜更新あり
|
手術用顕微鏡の世界市場:規模、シェア、動向分析(2024年~2030年):MedCore - 眼科/検眼用顕微鏡、脳神経外科/脊椎用顕微鏡、耳鼻咽喉科用顕微鏡、形成外科用顕微鏡 |
出版日: 2023年11月02日
発行: iData Research Inc.
ページ情報: 英文 38 Pages
納期: 即日から翌営業日
|
2023年、世界の手術用顕微鏡の市場規模は9億1,000万米ドルに達するとみられています。同市場は今後、予測期間中は着実に増加し、年間平均成長率(CAGR)は4.5%で、2030年までに12億米ドル以上に達すると予測されています。
画像誘導手術(IGS)、特に低侵襲手術は、手術室でますます一般的になってきています。こうした手術の多くは、IGSシステムと互換性のある手術用顕微鏡に依存しています。技術の進歩が進むにつれ、IGSの手法はより幅広い手技に拡大し、手術用顕微鏡の需要増につながると予想されます。
2023年、Carl Zeiss Meditecが最大の設置台数を誇り、手術用顕微鏡市場をリードしました。同社の神経外科向け主力製品であるKINEVO(R)900には、革新的なロボット可視化システムが組み込まれています。Carl Zeiss Meditecは、OPMI(R)Vario/S88を含む包括的な手術用顕微鏡を提供しており、脳神経外科、脊椎外科、形成再建外科、耳鼻咽喉科に対応しています。
Leica Microsystemsは、科学界からのフィードバックによる技術革新を重視し、手術用顕微鏡市場で第2位の地位を確保しました。TrueVision(R)3D Surgicalとの提携により、別個の3Dカートを必要としないデジタル・スマート3Dシステムを提供しています。同社の主力製品であるARveo(R)顕微鏡は、複雑な脳神経外科手術に対応し、リアルタイムの精度を実現するデジタル拡張現実(AR)を統合しています。
2023年の手術用顕微鏡市場では、眼科診断・治療ソリューションに特化したAlconが第3位を獲得しました。同社の眼科用顕微鏡LuxOR(TM)製品群、特にLuxOR(TM)LX3 with Q-VUE(TM)は白内障屈折矯正手術用に設計されており、米国市場で人気を博しています。
当レポートでは、世界の手術用顕微鏡市場について調査し、市場の概要とともに、セグメント別、地域別動向、競合情勢などを提供しています。
In 2023, the global surgical microscope market reached a value of $910 million. Forecasts suggest a steady increase over the forecast period, with a Compound Annual Growth Rate (CAGR) of 4.5%, reaching over $1.2 billion.
This extensive medical market research involved the analysis of over 15 surgical microscope companies across 7 continents. Utilizing a comprehensive methodology, we examined market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite on the global market for surgical microscopes encompasses various types, including ophthalmology/optometry microscopes, neurosurgery/spine microscopes, ear, nose, and throat (ENT) microscopes, and plastic reconstructive microscopes.
Image-guided surgeries (IGS), particularly in minimally invasive procedures, are increasingly common in operating rooms. Many of these procedures rely on surgical microscopes compatible with the IGS system. As technological advancements continue, IGS methods are expected to extend to a wider range of procedures, leading to an increased demand for surgical microscopes.
In 2023, Carl Zeiss Meditec took the lead in the surgical microscope market with the largest installed base. Their flagship product for neurosurgery, the KINEVO® 900, incorporates the innovative Robotic Visualization System. Carl Zeiss Meditec offers a comprehensive range of surgical microscopes, including the OPMI® Vario/S88, catering to neurosurgery, spinal surgery, plastic reconstructive surgery, and ENT surgery.
Leica Microsystems secured the second position in the surgical microscope market, emphasizing innovation driven by feedback from the scientific community. Through a partnership with TrueVision® 3D Surgical, they provide digital smart 3D systems that eliminate the need for separate 3D carts. The ARveo® microscope, their flagship product, is tailored for complex neurosurgery procedures and integrates digital augmented reality for real-time precision.
Alcon claimed the third position in the 2023 surgical microscope market, specializing in ophthalmic diagnostic and treatment solutions. Their LuxOR™ line of ophthalmic microscopes, particularly the LuxOR™ LX3 with Q-VUE™, is designed for cataract refractive surgery and has gained popularity in the U.S. market.
Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2023
Forecast: 2024-2030
Historical Data: 2020-2023
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.